{"id":58332,"date":"2023-11-01T10:01:53","date_gmt":"2023-11-01T09:01:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/"},"modified":"2023-11-01T10:01:53","modified_gmt":"2023-11-01T09:01:53","slug":"nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/","title":{"rendered":"NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available"},"content":{"rendered":"
\n

\nLeading researchers in breast and pancreatic cancer share first insights utilizing the GeoMx Immuno-oncology Proteome Atlas<\/p>\n

SEATTLE–(BUSINESS WIRE)–NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoString at the 38th<\/sup> annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held in San Diego, CA.<\/p>\n

<\/a>
<\/a><\/p>\n

\nDr. Aubrey Thompson of the Mayo Clinic and Amaya Pankaj, a research fellow from Dr. David Ting\u2019s Lab at Massachusetts General Hospital, will share the first data from NanoString\u2019s newest assay for the GeoMx\u00ae Digital Spatial Profiler (DSP). The GeoMx Immuno-oncology Proteome Atlas (IPA) is the industry\u2019s most comprehensive spatial proteomics panel, enabling unprecedented spatial profiling of more than 570+ relevant targets from FFPE (Formalin-Fixed, Paraffin-Embedded) tissue sections.<\/p>\n

\nDr. Thompson will share a comparison of early-stage HER2+ tumor biopsies from patients, both responders and non-responders to neoadjuvant treatment. \u201cThe ability to interrogate the abundance and spatial distribution of 570 proteins is little short of breathtaking,\u201d said Dr. Thompson. He added, \u201cThe initial data that we have generated using the IPA assay are very provocative, and we look forward to using these exciting new reagents to further explore the spatial biology of breast cancer.\u201d<\/p>\n

\nThe GeoMx IPA assay offers researchers more than five times the content of any competing panel, providing access to unparalleled information. Its utility is applicable to the search for novel biomarkers and drug targets, investigating therapeutic response, stratifying patients, and determining drug mechanisms of action.<\/p>\n

\nNanoString will host a lunchtime symposium on Friday, November 3rd<\/sup>, entitled Revolutionizing Immuno-oncology with Spatial Biology<\/i>. The workshop will feature a presentation by Ms. Pankaj from David Ting\u2019s Lab on the dissection of pancreatic tumor cells by harnessing spatial multiomics using two NanoString products on the same slide, the GeoMx IPA for protein and the Whole Transcriptome Atlas for RNA. NanoString\u2019s Chief Scientific Officer and SVP of R&D, Dr. Joseph Beechem, and Senior Director of Product Management, Vik Devgan, also will provide an overview of NanoString\u2019s spatial biology solutions, applications and high-level product roadmap. The workshop will be held from 12:15 \u2013 1:15 p.m. (PT) in room 16 AB.<\/p>\n

\nWith its partners Abcam and Visiopharm, NanoString will host an IPA happy hour from 5:00-7:00 p.m. also on November 3rd<\/sup> at its conference booth, number 213. Both partners will participate in all events and be available at NanoString\u2019s booth during the conference to provide additional information.<\/p>\n

\n\u201cNanoString is honored to offer customers the unprecedented utility and power encapsulated in the new GeoMx IPA assay. We look forward to many opportunities during SITC to discuss its transformative potential for researchers,\u201d said Brad Gray, President and CEO of NanoString.<\/p>\n

\nThe GeoMx IPA is available for pre-order now and will commence shipment in November 2023.<\/p>\n

\nAbout NanoString Technologies, Inc.<\/b><\/p>\n

\nNanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx\u00ae Digital Spatial Profiler is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics. The CosMx\u2122 Spatial Molecular Imager is a single-cell imaging platform powered by spatial multiomics enabling researchers to map single cells in their native environments to extract deep biological insights and novel discoveries from one experiment. The AtoMx\u2122 Spatial Informatics Platform is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. At the foundation of our research tools is our nCounter\u00ae Analysis System, which offers a secure way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. For more information, visit www.nanostring.com<\/a>.<\/p>\n

\nThe NanoString logo, NanoString, NanoString Technologies, GeoMx, CosMx, AtoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc., in the United States and other countries.<\/p>\n

Contacts<\/b> <\/p>\n

\nDoug Farrell, NanoString
\n
Vice President, Investor Relations & Corporate Communications
\n
dfarrell@nanostring.com<\/a>
Phone: 206-602-1768<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Leading researchers in breast and pancreatic cancer share first insights utilizing the GeoMx Immuno-oncology Proteome Atlas SEATTLE–(BUSINESS WIRE)–NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoString at the 38th annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58332","6":"format-standard","7":"category-industry"},"yoast_head":"\nNanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Leading researchers in breast and pancreatic cancer share first insights utilizing the GeoMx Immuno-oncology Proteome Atlas SEATTLE–(BUSINESS WIRE)–NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoString at the 38th annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-01T09:01:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231101806981\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available\",\"datePublished\":\"2023-11-01T09:01:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/\"},\"wordCount\":684,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231101806981\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/\",\"name\":\"NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231101806981\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\",\"datePublished\":\"2023-11-01T09:01:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231101806981\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231101806981\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/","og_locale":"en_US","og_type":"article","og_title":"NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available - Pharma Trend","og_description":"Leading researchers in breast and pancreatic cancer share first insights utilizing the GeoMx Immuno-oncology Proteome Atlas SEATTLE–(BUSINESS WIRE)–NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoString at the 38th annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/","og_site_name":"Pharma Trend","article_published_time":"2023-11-01T09:01:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231101806981\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available","datePublished":"2023-11-01T09:01:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/"},"wordCount":684,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231101806981\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/","url":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/","name":"NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231101806981\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","datePublished":"2023-11-01T09:01:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231101806981\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231101806981\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/nanostring-customers-present-first-data-using-the-most-comprehensive-spatial-proteomics-panel-available\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58332"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58332\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}